Kyverna Therapeutics (KYTX) Shares Issued (2023 - 2026)

Kyverna Therapeutics (KYTX) has 4 years of Shares Issued data on file, last reported at $243000.0 in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 8000.0% year-over-year to $243000.0; the trailing twelve-month figure through Mar 2026 stood at $99.2 million (up 3306833.33% YoY), and the FY2025 full-year result was $99.0 million, down 70.99% from the prior year.
• Shares Issued for Q1 2026 stood at $243000.0, down from $97.3 million in the prior quarter.
• Across five years, Shares Issued topped out at $341.2 million in Q1 2024 and bottomed at $3000.0 in Q1 2025.
• The 4-year median for Shares Issued is $275000.0 (2023), against an average of $49.0 million.
• The widest annual swing landed in 2024, when Shares Issued soared 1421445.83%; it then tumbled 100.0% in 2025.
• A 4-year view of Shares Issued shows it stood at $275000.0 in 2023, then soared by 123962.18% to $341.2 million in 2024, then tumbled by 71.48% to $97.3 million in 2025, then tumbled by 99.75% to $243000.0 in 2026.
• The last three Shares Issued figures came in at $243000.0 (Q1 2026), $97.3 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.

Peer Comparison